US Equity
NKTR
— NEKTAR THERAPEUTICSNektar Therapeutics is a biopharmaceutical company that develops drug candidates using its proprietary polymer conjugate technology platform for cancer and immunology.
💰 Market cap: $2.41B📍 455 Mission Bay Boulevard South, SAN FRANCISCO, CA, 94158 US🏷️ Biotechnology & Medical Research💵 Previous close: $70.72🔢 4,516 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $70.72 |
| 2026-07-23 | $69.36 |
| 2026-07-22 | $69.32 |
| 2026-07-21 | $68.67 |
| 2026-07-20 | $64.84 |
| 2026-07-17 | $68.26 |
| 2026-07-16 | $67.05 |
| 2026-07-15 | $68.30 |
| 2026-07-14 | $67.17 |
| 2026-07-13 | $68.32 |
| 2026-07-10 | $70.36 |
| 2026-07-09 | $72.92 |
| 2026-07-08 | $71.90 |
| 2026-07-07 | $74.90 |
| 2026-07-06 | $73.15 |
| 2026-07-02 | $71.04 |
| 2026-07-01 | $64.39 |
| 2026-06-30 | $69.81 |
| 2026-06-29 | $65.39 |
| 2026-06-26 | $63.65 |
| 2026-06-25 | $62.03 |
| 2026-06-24 | $64.84 |
| 2026-06-23 | $66.69 |
| 2026-06-22 | $65.70 |
| 2026-06-18 | $60.98 |
| 2026-06-17 | $60.92 |
| 2026-06-16 | $60.27 |
| 2026-06-15 | $61.15 |
| 2026-06-12 | $59.38 |
| 2026-06-11 | $59.21 |
| 2026-06-10 | $56.78 |
| 2026-06-09 | $56.23 |
| 2026-06-08 | $56.62 |
| 2026-06-05 | $57.32 |
| 2026-06-04 | $59.31 |
| 2026-06-03 | $59.23 |
| 2026-06-02 | $58.56 |
| 2026-06-01 | $63.86 |
| 2026-05-29 | $64.88 |
| 2026-05-28 | $65.01 |
| 2026-05-27 | $65.40 |
| 2026-05-26 | $65.56 |
| 2026-05-22 | $66.61 |
| 2026-05-21 | $68.58 |
| 2026-05-20 | $69.49 |
| 2026-05-19 | $67.58 |
| 2026-05-18 | $68.43 |
| 2026-05-15 | $70.62 |
| 2026-05-14 | $74.33 |
| 2026-05-13 | $75.95 |
| 2026-05-12 | $78.43 |
| 2026-05-11 | $78.72 |
| 2026-05-08 | $81.89 |
| 2026-05-07 | $83.37 |
| 2026-05-06 | $85.09 |
| 2026-05-05 | $84.16 |
| 2026-05-04 | $86.89 |
| 2026-05-01 | $86.46 |
| 2026-04-30 | $85.04 |
| 2026-04-29 | $83.20 |
| 2026-04-28 | $83.81 |